Open original FDA record ↗Recall record
- FDA identifier
- Z-1683-2021
- Company in FDA record
- Radiometer Medical ApS
- FDA record creation date
- May 26, 2021
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
Radiometer has become aware of an issue with PICO70 Arterial Blood Sampler. The issue relates to the sterile barrier system for the product. During internal stress testing on PICO70 Arterial Blood Samplers a breach in the sterile barrier system was observed in one sample. Risk for the patient: The described error is considered to have a remote possibility of resulting in bacterial bloodstream infection. The bloodstream infection may be asymptomatic but may also progress to sepsis or life-threatening septic shock. Immunosuppressed patients are at particular risk. Due to issues (breaches) with the sterile barrier system for the Arterial Blood Sampler.
Source facts
- Action
- On 03/26/2021, the firm initially sent an "Urgent: Medical Device Recall" Notification Letter via email and followed up with a hardcopy via FedEx. The Notification Letter informed customers that the Recalling Firm had become aware of an issue related to the sterile barrier system for its arterial blood sampler product. The potential risks associated with the affected products could potentially be bacterial bloodstream infection with immunosuppressed patients being at particular risk. Customers are instructed to: 1) Check their inventory of the affected Arterial Blood Samplers 2) Check for the affected Arterial Blood Samplers that were distributed within their institution. 3) Collect any of the affected Arterial Blood Samplers 4) Complete the Recall Response Form (last page of this letter) and return to the fax number listed on the form. 5) For U.S. Customer return affected Arterial Blood Samplers to: Radiometer America 810 Sharon Drive Westlake, OH, 44145 Attn: RGA (ID) Any questions, contact 1-800-736-0600 option 1, Monday - Friday 9am to 7pm (EST).
- Initiated
- 2021-03-26
- Root cause
- Under Investigation by firm
- Terminated
- 2023-03-01
- Distribution
- Worldwide distribution - U.S. Nationwide distribution in the states of CA, CO, FL, IL, LA, MA, MI, MO, MT, NJ, NY, OK, PA, TX, WA, and WI. The countries of Australia, New Zealand, Canada, Algeria, Bahrain, Belarus, Bosnia and Herzegovina, Colombia, Costa Rica, Ethiopia, Greece, Guatemala, Indonesia, Lebanon, Lithuania, Malawi, Mali, Oman, Peru, Romania, Saudi Arabia, Senegal, Uganda, United Arab Emirates, Austria, Belgium, Netherlands, Luxembourg, China, Taiwan, Croatia, Czech Republic, Slovakia, Denmark, Faroe Islands, Iceland, Finland, France, Germany, Hungary, India, Maldives, Italy, Japan, Kazakhstan, Mexico, Norway, Poland, Russia, South Africa, Spain, Sweden, Switzerland, Turkey, Georgia, and United Kingdom.
- Recall number
- Z-1683-2021
- Recall status
- Terminated
- CDRH record ID
- 187268
- FDA record created
- 2021-05-26
- Recall event number
- 87867